Latest available resultsQuarter ended June 30, 202610-Q · July 24, 2026
Filed with the SECCME GROUP INC.
CMEFinance & insurance
Next reportOctober 20, 2026pre-market · Analyst forecast 2.969 $/share
Revenue
$1.71B
▲ +0.8% vs prior year% YoY
Net income
$1.04B
▲ +1.6% vs prior year% YoY
EPS
2.88$
▲ +2.5% vs prior year% YoY
Net margin
61.1%
▲ +0.5 percentage points vs prior year pp YoY
Revenue▲ +0.8 %
Margins (% of revenue)Gross N/AOperatingNet
Net income▲ +1.6 %
EPS▲ +2.5 %
View financial tableQuarter ended June 30, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $1.71B | |
| Gross profit | — | never filed |
| Operating income | $1.11B | 64.9 % |
| Net income | $1.04B | 61.1 % |
| R&D | — | never filed |
| EPS (diluted) | 2.88 $ | |
| Balance sheet | ||
| Assets | $194.68B | |
| Liabilities | $168.16B | |
| Equity | $26.52B | |
| Cash | $2.14B | |
| Capital | ||
| Shares outstanding | — | |
| Public float | — | |